| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/17/1998 | US5719278 Tricyclic benzazepine vasopressin antagonists |
| 02/17/1998 | US5719277 Diamine salts of clavulanic acid |
| 02/17/1998 | US5719197 Drug delivery |
| 02/17/1998 | US5719196 Method of treating respiratory infections or complications derived therefrom in humans which includes oral administration of xylitol |
| 02/17/1998 | US5719195 Using a particlular isomer; skin disorders |
| 02/17/1998 | US5719194 Prevention and treatment of topical viral infections with perfluoropolyethers or compositions thereof |
| 02/17/1998 | US5719193 Method of potentiating cell-mediated immunity utilizing polyamine derivatives |
| 02/17/1998 | US5719192 Orally administering to treat pneumocystis carinii pneumonia |
| 02/17/1998 | US5719191 Administering 1,1,2-triphenylbut-1-ene derivatives |
| 02/17/1998 | US5719190 Inhibition of myeloperoxidase activity |
| 02/17/1998 | US5719189 Containing triphenylmethane |
| 02/17/1998 | US5719188 Use of insulin sensitizing agents to treat hypertension |
| 02/17/1998 | US5719187 Compounds having a guanidine structure and pharmaceutical composition containing same |
| 02/17/1998 | US5719186 Central muscle relaxants, anxiolytic agents, antiinflammatory agents, analgesics, anticonvulsants |
| 02/17/1998 | US5719185 Use for GABA agonists for treating emesis |
| 02/17/1998 | US5719184 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds |
| 02/17/1998 | US5719181 Treatment of central nervous system disorders |
| 02/17/1998 | US5719180 Chroman derivatives having vitamin E-like activities |
| 02/17/1998 | US5719178 Methods and compositions for treating attention-deficit/hyperactivity disorder |
| 02/17/1998 | US5719177 Antitumor agents |
| 02/17/1998 | US5719175 Protein kinase C inhibitors |
| 02/17/1998 | US5719173 Administering a benzimidazole carboxylate |
| 02/17/1998 | US5719170 Glucose-6-phosphatase inhibitor; antidiabetic agent |
| 02/17/1998 | US5719169 Substituted benzoylguanidines, their use as a medicament or diagnostic, and medicament containing them |
| 02/17/1998 | US5719168 Acetamide derivatives and their use as feeding behaviour modifiers |
| 02/17/1998 | US5719167 Angiostatic compounds |
| 02/17/1998 | US5719166 Treating psychoses |
| 02/17/1998 | US5719165 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism |
| 02/17/1998 | US5719164 Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates |
| 02/17/1998 | US5719163 Arthritis |
| 02/17/1998 | US5719162 Fibrinogen receptor antagonists |
| 02/17/1998 | US5719161 Alkoxy alkyl carbamates of imidazo(1.2-a)pyridines |
| 02/17/1998 | US5719160 Method for modifying and regulating lipid metabolism |
| 02/17/1998 | US5719159 4-azasteroids with side-chain fluoroketones |
| 02/17/1998 | US5719158 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
| 02/17/1998 | US5719157 Osteoporosis |
| 02/17/1998 | US5719155 Cardiovascular disorders |
| 02/17/1998 | US5719154 Treating microbial infections in humans and animals |
| 02/17/1998 | US5719149 Morpholine derivatives and their use as therapeutic agents |
| 02/17/1998 | US5719148 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/17/1998 | US5719144 Fibrinogen receptor antagonists |
| 02/17/1998 | US5719143 Polysubstituted 3-acylamino-5-phenyl-1, 4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |
| 02/17/1998 | US5719141 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide derivatives |
| 02/17/1998 | US5719140 2, 3-, 4-, 5-, 6-, 7-, 8-, 9- and /or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/17/1998 | US5719139 9-oxo-1-azabicyclo 5.2.0!non-2,4-diene-2-carboxylic acid compounds as antibiotics |
| 02/17/1998 | US5719138 Contacting with a dicitrate cyclic diester |
| 02/17/1998 | US5719137 Method of preventing neurodegeneration and cognitive dysfunction using 17α-dihydroequilenin |
| 02/17/1998 | US5719136 Combination of progesterone antagonists and antiestrogens with partial agonistic action for hormone substitution therapy for perimenopausal and postmenopausal women |
| 02/17/1998 | US5719135 Tyrosine kinase inhibitors |
| 02/17/1998 | US5719129 Sunscreen agents, antiaging agent, free radical scavenger |
| 02/17/1998 | US5718923 Melt granulated sucralfate preparations and a process for their production |
| 02/17/1998 | US5718919 Nanoparticles containing the R(-)enantiomer of ibuprofen |
| 02/17/1998 | US5718917 PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction |
| 02/17/1998 | US5718915 Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme |
| 02/17/1998 | US5718892 Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 02/17/1998 | US5718888 Deodorant active-substance combinations made from wool-grease acids and partial glycerides |
| 02/17/1998 | US5718388 Continuously feeding therapeutical or imaging agents and rigid grinding media to a milling chamber, contacting the agent with grinding media to reduce particle size, continuously removing and separating |
| 02/17/1998 | CA2101252C Process for preparing trans-piperidine-2,5- dicarboxylates |
| 02/17/1998 | CA2080566C Pharmaceutical compositions containing triazole derivatives for rectal administration |
| 02/17/1998 | CA2026516C Injectable preparations containing cephalosporin medicament |
| 02/17/1998 | CA2001727C Organic compounds |
| 02/17/1998 | CA1339675C Method for the preparation of tetrahydrofolates |
| 02/15/1998 | CA2209540A1 Anti-infective against std relating, for example, to hiv, chlamydia, gonococcus, treponema pallidum or herpes simplex and device used to preserve/mix principal ingredient and baseof such anti-infective |
| 02/12/1998 | WO1998005793A1 Method for preparing a polydispersed saccharide composition and resulting polydispersed saccharide composition |
| 02/12/1998 | WO1998005784A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 02/12/1998 | WO1998005782A1 Testis-specific insulin homolog polypeptides |
| 02/12/1998 | WO1998005776A2 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | WO1998005775A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 02/12/1998 | WO1998005769A2 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
| 02/12/1998 | WO1998005755A1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 02/12/1998 | WO1998005678A2 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 02/12/1998 | WO1998005673A1 Methods for purifying nucleic acids |
| 02/12/1998 | WO1998005670A1 Substituted n-isothiazolyl-(thio)amides |
| 02/12/1998 | WO1998005669A1 Total synthesis of antitumor acylfulvenes |
| 02/12/1998 | WO1998005661A1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 02/12/1998 | WO1998005660A1 Pyrrolo(3,2-c) quinoline derivatives |
| 02/12/1998 | WO1998005659A1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
| 02/12/1998 | WO1998005654A1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals |
| 02/12/1998 | WO1998005648A1 Novel isoquinoline derivatives |
| 02/12/1998 | WO1998005642A1 Cftr channel activator compounds and pharmaceutical compositions containing same |
| 02/12/1998 | WO1998005637A1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a¿2? |
| 02/12/1998 | WO1998005635A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 02/12/1998 | WO1998005360A2 Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes |
| 02/12/1998 | WO1998005358A1 Sustained release preparations for injection containing gabexate mesylate |
| 02/12/1998 | WO1998005357A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
| 02/12/1998 | WO1998005356A1 NOVEL FtsL |
| 02/12/1998 | WO1998005352A1 Hypothalamus-specific polypeptides |
| 02/12/1998 | WO1998005350A1 Materials and methods for treatment of plaquing diseases |
| 02/12/1998 | WO1998005349A1 A novel method of detecting and treating cancer |
| 02/12/1998 | WO1998005341A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 02/12/1998 | WO1998005340A1 Promotion of wound healing by chemically-modified tetracyclines |
| 02/12/1998 | WO1998005339A1 Use of ursodeoxycholic acid in hiv infection |
| 02/12/1998 | WO1998005338A2 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| 02/12/1998 | WO1998005337A1 Use of gaba and nmda receptor ligands for the treatment of migraine headache |
| 02/12/1998 | WO1998005336A1 Inhibitors of cysteine protease |
| 02/12/1998 | WO1998005335A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a) |
| 02/12/1998 | WO1998005334A1 Fat emulsion containing xanthine derivative |
| 02/12/1998 | WO1998005333A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | WO1998005332A1 Novel heterocycle compositions |
| 02/12/1998 | WO1998005331A2 Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |